Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation

Australian and New Zealand Journal of Psychiatry

Volumn 48, Issue 8, 2014, Pages 722-734

  Catts, Vibeke Sørensen ^a,b   Wong, Jenny ^c   Fillman, Stu Gregory ^a,b   Fung, Samantha Jane ^a,b   Shannon Weickert, Cynthia ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Astrocytes; glial fibrillary acidic protein; gliosis; inflammation; neurodegeneration

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ADULT; AGED; ASTROCYTE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTROCYTES; BIOMARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREFRONTAL CORTEX; REAL-TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84905903005     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867414531078     Document Type: Article

References (56)

1. Arif M, Chikuma T, Ahmed MM, et al. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions. Neuroscience Research. 2007 ; 57: 248-258
2. Arion D, Unger T, Lewis DA, et al. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biological Psychiatry. 2007 ; 62: 711-721
3. Arnold SE, Franz BR, Trojanowski JQ, et al. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica. 1996 ; 91: 269-277
4. Arnold SE, Trojanowski JQ, Gur RE, et al. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Archives of General Psychiatry. 1998 ; 55: 225-232
5. Balasingam V, Dickson K, Brade A, et al. Astrocyte reactivity in neonatal mice: Apparent dependence on the presence of reactive microglia/macrophages. Glia. 1996 ; 18: 11-26
6. Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophrenia Research. 2009 ; 112: 54-64
7. Bayer TA, Buslei R, Havas L, et al. Evidence for activation of microglia in patients with psychiatric illnesses. Neuroscience Letters. 1999 ; 271: 126-128
8. Bruton CJ, Crow TJ, Frith CD, et al. Schizophrenia and the brain: A prospective clinic-neuropathological study. Psychological Medicine. 1990 ; 20: 285-304
9. Busse S, Busse M, Schiltz K, et al. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?. Brain, Behavior, and Immunity. 2012 ; 26: 1273-1279
10. Casanova MF, Stevens JR, Kleinman JE. Astrocytosis in the molecular layer of the dentate gyrus: A study in Alzheimer's disease and schizophrenia. Psychiatry Research. 1990 ; 35: 149-166
11. Collin G, Derks EM, van Haren NEM, et al. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 2012 ; 138: 171-176
12. Damadzic R, Bigelow LB, Krimer LS, et al. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: Absence of significant astrocytosis. Brain Research Bulletin. 2001 ; 55: 611-618
13. Dean B, Gray L, Scarr E. Regionally specific changes in levels of cortical S100β in bipolar 1 disorder but not schizophrenia. Australian and New Zealand Journal of Psychiatry. 2006 ; 40: 217-224
14. Doorduin J, de Vries EFJ, Willemsen ATM, et al. Neuroinflammation in schizophrenia-related psychosis: A PET study. Journal of Nuclear Medicine. 2009 ; 50: 1801-1807
15. Falkai P, Honert WG, Bogerts B, et al. No evidence for astrogliosis in brains of schizophrenia patients: A post-mortem study. Neuropathology and Applied Neurobiology. 1999 ; 25: 48-53
16. Feresten AH, Barakauskas V, Ypsilanti A, et al. Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness. Schizophrenia Research. 2013 ; 150: 252-257
17. Fillman SG, Cloonan N, Catts VS, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Molecular Psychiatry. 2013 ; 18: 206-214
18. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988 ; 75: 800-802
19. Hwang Y, Kim J, Shin J-Y, et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Translational Psychiatry. 2013 ; 3: e321
20. Johnston-Wilson NL, Sims CD, Hofmann J-P, et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Molecular Psychiatry. 2000 ; 5: 142-149
21. Kaaijk P, Pals ST, Morsink F, et al. Differential expression of CD44 splice variants in the normal human central nervous system. Journal of Neuroimmunology. 1997 ; 73: 70-76
22. Kano S-I, Nwulia E, Niwa M, et al. Altered MHC class I expression in dorsolateral prefrontal cortex of non-smoker patients with schizophrenia. Neuroscience Research. 2011 ; 71: 289-293
23. Katsel P, Byne W, Roussos P, et al. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology. 2011 ; 36: 1171-1177
24. Konopaske GT, Dorph-Petersen K-A, Sweet RA, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biological Psychiatry. 2008 ; 63: 759-765
25. Middeldorp J, Hol EM. GFAP in health and disease. Progress in Neurobiology. 2011 ; 93: 421-443
26. Nichols NR, Day JR, Laping NJ, et al. GFAP mRNA increases with age in rat and human brain. Neurobiology of Aging. 1993 ; 14: 421-429
27. Niizato K, Iritani S, Ikeda K, et al. Astroglial function of schizophrenic brain: A study using lobotomized brain. Neuroreport. 2001 ; 12: 1457-1460
28. Norton WT, Aquino DA, Hozumi I, et al. Quantitative aspects of reactive gliosis: A review. Neurochemical Research. 1992 ; 17: 877-885
29. Pantazopoulos H, Woo TUW, Lim MP, et al. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Archives of General Psychiatry. 2010 ; 67: 155-166
30. Radewicz K, Laurence JG, Gentleman SM, et al. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. Journal of Neuropathology and Experimental Neurology. 2000 ; 59: 137-150
31. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cerebral Cortex. 1995 ; 5: 307-322
32. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial soma size in the prefrontal cortex. A post-mortem morphometric study of schizophrenia and Huntington Disease. Archives of General Psychiatry. 1998 ; 55: 215-224
33. Rao JS, Kim HW, Harry GJ, et al. Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophrenia Research. 2013 ; 147: 24-31
34. Roberts GW, Colter N, Lofthouse R, et al. Gliosis in schizophrenia: A survey. Biological Psychiatry. 1986 ; 21: 1043-1050
35. Roberts GW, Colter N, Lofthouse R, et al. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biological Psychiatry. 1987 ; 22: 1459-1468
36. Saetre P, Emilsson L, Axelsson E, et al. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry. 2007 ; 7: 46
37. Schnieder TP, Dwork AJ. Searching for neuropathology: Gliosis in schizophrenia. Biological Psychiatry. 2011 ; 69: 134-139
38. Selemon LD, Lidow MS, Goldman-Rakic PS. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biological Psychiatry. 1999 ; 46: 161-172
39. Siegel BI, Senqupta EJ, Edelson JR, et al. Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Biological Psychiatry. 2013 ;:
40. Spooren A, Kolmus K, Laureys G, et al. Interleukin-6, a mental cytokine. Brain Research Review. 2011 ; 67: 157-183
41. Steffek AE, McCulllumsmith RE, Haroutunian V, et al. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophrenia Research. 2008 ; 103: 71-82
42. Steiner J, Bielau H, Brisch R, et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. Journal of Psychiatric Research. 2008 ; 42: 151-157
43. Steiner J, Mawrin C, Ziegeler A, et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathologica. 2006 ; 112: 305-316
44. Stevens CD, Altshuler LL, Bogerts B, et al. Quantitative study of gliosis in schizophrenia and Huntington's chorea. Biological Psychiatry. 1988 ; 24: 697-700
45. Stevens JR. Neuropathology of schizophrenia. Archives of General Psychiatry. 1982 ; 39: 1131-1139
46. Takano A, Arakawa R, Ito H, et al. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: A PET study with [11C]DAA1106. International Journal of Neuropsychopharmacology. 2010 ; 13: 943-950
47. Toro CT, Hallak JEC, Dunham JS, et al. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neuroscience Letters. 2006 ; 404: 276-281
48. Van Berckel BN, Bossong MG, Boellaard R, et al. Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study. Biological Psychiatry. 2008 ; 64: 820-822
49. Walters JTR, Corvin A, Owen MJ, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Archives of General Psychiatry. 2010 ; 67: 692-700
50. Webster MJ, O'Grady J, Kleinman JE, et al. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience. 2005 ; 133: 453-461
51. Weickert C, Sheedy D, Rothmond D, et al. Selection of reference gene expression in a schizophrenia brain cohort. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 59-70
52. Weickert TW, Goldberg TE, Gold JM, et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry. 2000 ; 57: 907-913
53. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry. 1987 ; 44: 660-669
54. Williams MR, Hampton T, Pearce PKB, et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2013 ; 263: 41-52
55. Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. Journal of Neuroscience. 2012 ; 32: 6391-6410
56. Zhang Y, Xu H, Jiang W, et al. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophrenia Research. 2008 ; 106: 182-191